Showing results (21-30 of 196) with videos related to
Sort By:
Pageof 20
British Medical Journal|November 1, 1975
Controlled trial of sodium valproate in severe epilepsyA Richens, S AhmadDrug Safety|May 1, 1994
A risk-benefit assessment of vigabatrin in the treatment of neurological disordersJ Srinivasan, A RichensClinical Pharmacokinetics|May 1, 1983
Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administrationF Pisani, A RichensJournal of Neurology, Neurosurgery, and Psychiatry|August 1, 1992
Bioavailability and dissolution of proprietary and generic formulations of phenytoinI Soryal, A RichensBritish Journal of Clinical Pharmacology|July 1, 1979
Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patientsE Perucca, A RichensBritish Journal of Clinical Pharmacology|December 1, 1981
Pharmacokinetics of diazepam in epileptic patients and normal volunteers following intravenous administrationS Dhillon, A RichensBritish Journal of Clinical Pharmacology|May 1, 1981
Methods of assessment of antiepileptic drugsN Milligan, A RichensClinical Pharmacology and Therapeutics|January 1, 1980
Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patientsA Monks, A RichensJournal of Neurology, Neurosurgery, and Psychiatry|June 1, 1980
Reversal by phenytoin of carbamazepine-induced water intoxication: a pharmacokinetic interactionE Perucca, A RichensPageof 20